Ivermectin Treatment Guidelines

Introduction to Ivermectin Dosage

• The standard dosing regimen for ivermectin in parasitic infections is typically 200 μg/kg as a single oral dose, with specific dosing adjustments based on the type of infection being treated, as recommended by the MMWR Recommendations and Reports, the Journal of Infection, and the Infectious Diseases of Poverty journal 1, 2, 3
• For crusted scabies, combination therapy with topical scabicide plus oral ivermectin 200 μg/kg on days 1, 2, 8, 9, and 15 is recommended by the MMWR Recommendations and Reports 1
• The Infectious Diseases of Poverty journal recommends a dose of 150-200 μg/kg, most often as a single dose, with some guidelines suggesting daily dosing for up to 10 days in endemic settings or repetitive administration at monthly, quarterly, or biannual intervals 3

Special Considerations

• The American Academy of Pediatrics recommends that ivermectin is not recommended for children weighing less than 15 kg due to risk of crossing the blood-brain barrier, and also notes that it is not FDA-approved as a pediculicide, but has shown promising results in topical 1% preparation 4
• For patients with liver disease, the safety of multiple doses in severe liver disease is not established, according to the MMWR Recommendations and Reports 1
• HIV patients can follow the same treatment regimen as HIV-negative individuals, as recommended by the MMWR Recommendations and Reports 1

Contraindications and Monitoring

• Co-existing onchocerciasis or loiasis should be excluded before administering ivermectin, as recommended by the American Academy of Pediatrics and the Journal of Infection 2, 4
• No adjustment of ivermectin dosage is required for persons with renal impairment, as stated by the MMWR Recommendations and Reports 1

Dosage and Administration

• The Centers for Disease Control and Prevention recommends re-evaluation if symptoms persist after 1 week, and also suggests decontaminating bedding and clothing by machine washing and drying using hot cycle, dry cleaning, or removing from body contact for at least 72 hours 1

Treatment Outcomes and Follow-up

• Ivermectin is generally well-tolerated with few adverse effects, and the response to ivermectin treatment is usually rapid, with improvement of symptoms within 24-48 hours, as reported by the MMWR Recommendations and Reports and the Journal of Infection 1, 2
• Complete resolution of skin lesions typically occurs within 7-14 days, with post-inflammatory changes such as hyperpigmentation persisting for several weeks after the infection has cleared, as noted by the Journal of Infection 2
• The Infectious Diseases Society of America recommends follow-up 2 weeks after treatment to confirm complete resolution of the infection, and considers repeating treatment or switching to an alternative agent if lesions persist beyond 2 weeks 2

Prevention and Control

• Preventive measures for cutaneous larva migrans include avoiding walking barefoot on beaches or soil in endemic areas, regular deworming of dogs and cats, and restricting animals from beaches and playgrounds, as recommended by the Journal of Infection 2
• Maintain indoor humidity between 35-50% to reduce mite populations, use HEPA vacuum cleaners on carpeting and upholstery, and consider treating carpets with acaricides like benzyl benzoate if removal isn't possible, as suggested by the Journal of Allergy and Clinical Immunology 5